Parkinsonism & Related Disorders

Title Publication Date Language Citations
Minimal clinically important difference on the Motor Examination part of MDS-UPDRS2015/12/01English168
Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort2012/07/01English162
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations2013/04/01English159
Health-related quality of life and alternative forms of exercise in Parkinson disease2009/11/01English159
Gut microbiota: Implications in Parkinson's disease2017/05/01English155
Gut microbiota in patients with Parkinson's disease in southern China2018/08/01English154
Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease2013/11/01English154
Freezer or non-freezer: Clinical assessment of freezing of gait2012/02/01English152
The association between motor subtypes and psychopathology in Parkinson's disease2009/06/01English151
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease2013/01/01English148
Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument2008/03/01English147
Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease2015/06/01English146
Impaired attention predicts falling in Parkinson's disease2009/02/01English145
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia2007/03/01English144
High intensity eccentric resistance training decreases bradykinesia and improves quality of life in persons with Parkinson's disease: A preliminary study2009/12/01English143
Adenosine, adenosine A2A antagonists, and Parkinson's disease2009/07/01English143
Neuroinflammatory processes in Parkinson's disease2005/06/01English142
Non-motor dysfunction in Parkinson's disease2007/08/01English141
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry2017/12/01English140
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program2015/10/01English138
Feasibility and effects of home-based smartphone-delivered automated feedback training for gait in people with Parkinson's disease: A pilot randomized controlled trial2016/01/01English137
Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol2008/07/01English135
Drooling in Parkinson's disease: A review2014/11/01English135
Tauopathies as clinicopathological entities2016/01/01English134
Diagnostic accuracy of parkinsonism syndromes by general neurologists2014/08/01English131
Impaired decision-making in Parkinson's disease2006/04/01English130
The economic impact of Parkinson's disease2007/09/01English129
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease?2014/04/01English129
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms2016/06/01English129
Oral and nasal microbiota in Parkinson's disease2017/05/01English129